Free shipping on all orders over $ 500

Cabazitaxel

Cat. No. M2483

All AbMole products are for research use only, cannot be used for human consumption.

Cabazitaxel  Structure
Synonym:

XRP6258; RPR-116258A; taxoid XRP6258

Size Price Availability Quantity
10mg USD 50  USD50 In stock
50mg USD 75  USD75 In stock
100mg USD 135  USD135 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Cabazitaxel (Jevtana) is a semi-synthetic derivative of a natural taxoid. Cabazitaxel (Jevtana) increases CYP3A enzyme activities in rat hepatocytes. The mean ex-vivo human plasma protein binding of Cabazitaxel (Jevtana) is 91.6%. Cabazitaxel (Jevtana) is rapidly and extensively metabolised into numerous metabolites. Cabazitaxel (Jevtana) demonstrates activity in several murine and human resistant cell lines. With a 4-day exposure to cabazitaxel, cytotoxicity is noted with relatively low cabazitaxel concentrations. Cabazitaxel (Jevtana) shows high antitumor activity in 3 human colorectal cell lines (HCT-116, HCT-8, and HT-29). In accompanying models, Cabazitaxel (Jevtana) has significant antitumor activity. In murine tumor xenografts (colon C38 and pancreas P03), Cabazitaxel (Jevtana) causes complete tumor regressions. Using SF-295 and U251 human glioblastoma cell lines, both orthotopic and subcutaneous murine xenografts are generated. Cabazitaxel (Jevtana) treatment leads to complete regression in the majority of subcutaneously implanted tumors. Cabazitaxel (Jevtana) has entered in a phase I clinical trial in the treatment of solid cancer. Cabazitaxel (Jevtana) plus Prednisone, Carboplatin has entered in a phase II clinical trial in the treatment of prostate cancer. Cabazitaxel is a semi-synthetic derivative of a natural taxoid.

Customer Product Validations & Biological Datas
Source Mol Pharm (2015). Figure 2. Cabazitaxel
Method Plasma Pharmacokinetics
Cell Lines Abcb1a/1b-/-, Abcg2-/- and Abcb1a/1b;Abcg2-/- mice
Concentrations 10 mg/kg
Incubation Time 8 h
Results Absorption of cabazitaxel was rapid, with a Tmax occurring at or before 30 minutes in all strains.
Source Mol Pharm (2015). Figure 1. Cabazitaxel
Method Transport Assays
Cell Lines MDCK-II parental cells
Concentrations 5 μM
Incubation Time 8 h
Results In MDCKII parental cells, there was modest but significant apically directed transport of cabazitaxel, which was completely inhibited by the ABCB1 inhibitor zosuquidar, suggesting some transport by the low-level endogenous canine ABCB1. In MDCKII-hABCB1 cells.
Protocol (for reference only)
Cell Experiment
Cell lines MCF-7 cells
Preparation method Parallel drug selections were initiated using 0.1 nmol/L cabazitaxel, a concentration that would inhibit growth in MCF-7 cells by 50% (IC50 value) with and without 2 μmol/L PSC-833. Selections continued by increasing the drug concentration in a stepwise manner up to a final concentration of 5 nmol/L cabazitaxel.
Concentrations 5 nmol/L
Incubation time 72 h
Animal Experiment
Animal models Male nude mice
Formulation 1% medium /0.1% Tween-20
Dosages 30 mg/kg
Administration i.v.
Chemical Information
Molecular Weight 835.93
Formula C45H57NO14
CAS Number 183133-96-2
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
References

[1] Martin SK, et al. Cancer Res. Multinucleation and Mesenchymal-to-Epithelial Transition Alleviate Resistance to Combined Cabazitaxel and Antiandrogen Therapy in Advanced Prostate Cancer.

[2] Duran GE, et al. Mol Cancer Ther. Mechanisms of resistance to cabazitaxel.

Related Products
PCL-PEG-MAL

PCL-PEG-MAL is an amphiphilic block copolymer consisting of polycaprolactone (PCL), polyethylene glycol (PEG) and maleimide (MAL) functional groups. PCL-PEG-MAL is used in targeted delivery systems, surface modification of nanomaterials, functionalisation of biomaterials and biosensing technologies for specific chemical linkages or biomolecular immobilisation.

DSPE-PEG-Streptavidin

DSPE-PEG-Streptavidin is an important biocoupling molecule widely used in biomedical research, especially in drug delivery, targeted therapies, immunodiagnostics and biosensors. Through the specific binding between streptavidin and biotin, DSPE-PEG-Streptavidin can help to achieve efficient loading and targeted action in targeted delivery systems. In addition, the molecule is widely used in molecular imaging and bioassays, especially for molecular recognition using the strong affinity between streptavidin and biotin in assay platforms that require high sensitivity and specificity.

E7107

E7107 is a first-in-class precursor messenger ribonucleic acid (pre-mRNA) spliceosome inhibitor.

KL044

KL044 is a stabilizer of the clock protein cryptochrome (CRY). KL044 is a potent chemical probe with a pEC50 value of 7.32, leading to the extension of the circadian period and repression of Per2 activity.

2-(2-Methylphenoxy)-4H-1,3,2-benzodioxaphosphorin 2-oxide

2-(2-Methylphenoxy)-4H-1,3,2-benzodioxaphosphorin 2-oxide is a biochemical material that can be used in scientific research.

  Catalog
Abmole Inhibitor Catalog




Keywords: Cabazitaxel , XRP6258; RPR-116258A; taxoid XRP6258 supplier, inhibitors, activators

All AbMole products are for research use only, cannot be used for human consumption or veterinary use. We do not provide products or services to individuals. Please comply with the intended use and do not use AbMole products for any other purpose.



Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2024 AbMole BioScience. All Rights Reserved.